Cereplast, Inc. (CERP-OTC: BB)
July 3, 2009 Issue
The Most Powerful Name In Corporate News and Information
With Oil Being A Limited Resource With Fluctuating Prices, Cereplast’s Founder, Chairman And CEO, Frederic Scheer, A Pioneer In Bio-Plastic, Has Been Focused On Being The Leader In The Transition From The Traditional Oil-Based Plastic To This New Environmentally Friendly, Sustainable Feedstock
Cereplast, Inc. (OTCBB: CERP) designs and
manufactures proprietary bio-based, sustainable plastics which are used as
substitutes for petroleum-based plastics in all major converting processes –
such as injection molding, thermoforming, blow molding and extrusions – at a
pricing structure that aims to be competitive with petroleum-based plastics.
On the cutting-edge of bio-based plastic material development, Cereplast now
offers resins to meet a variety of customer demands. Cereplast Compostables®
resins are ideally suited for single use applications where high bio-based
content and compostability are advantageous, especially in the food service
industry. Cereplast Hybrid Resins® combine high bio-based content
with the durability and endurance of traditional plastic, making them ideal
for applications in industries such as automotive, consumer electronics and
Mr. Scheer became involved in the biodegradable plastics industry in 1994 through Montedison SpA, a large chemical conglomerate operating Novamont SpA, an Italian resin manufacturer and research company. Foreseeing that the demand for biodegradable products in North America would expand rapidly by the end of the decade, Scheer secured the exclusive distribution rights in North America for Mater-Bi™ resins. Soon thereafter, he began North American distribution of Mater-Bi, a 100% biodegradable resin patented and produced by Novamont.
Interview conducted by: Lynn Fosse, Senior Editor, CEOCFOinterviews.com, Published – July 3, 2009
CEOCFO: Has that happened?
Mr. Scheer: “The answer is yes and no. It is yes in the sense that surely Cereplast is a leader in this industry. However, it is no in the sense that it is taking longer than I was expecting. If you compare bioplastic to the rest of the alternative technologies bio-plastic has been the industry, which has been taking the longest to develop. In the early 2000’s a lot of alternative technologies started to grow such as ethanol, bio-diesel, solar, wind but bio-plastic take off was slower. It is starting to happen now. I look at the growth of our company we double our revenue year-to-year, and this trend is the same for other bioplastic companies. As an industry, we estimate that we will have an average growth of about 20% a year for the next five years, but even if it is very significant, we have not been really what I call the “darling of Wall Street”. That should change in the months and years to come. If I look at the amount of investments made in the ethanol business, it is in billions of dollars for the bio-plastic industry it is substantially lower.”
CEOCFO: What is the production process?
Mr. Scheer: “Basically, in laymen’s terms, we do exactly the same thing that traditional plastics companies are doing. To make the plastic products that people are used to, from automotive to consumer products to food service where things are made of plastic, you need to have a building block. This building block is called a plastic resin. Plastic resins present themselves as little pellets called a resin. This is what we create here at Cereplast. We basically create the building blocks that will allow plastic fabricators to create any kind of bio-plastic product to substitute traditional petroleum based products. If I look at the way the bio-plastic industry and all the traditional plastic industry are organized, you have basically three steps.
1. The first step is drilling of oil, and here instead of drilling, it is basically farming of corn or tapioca or different kind of plants.
2. The second step consists of transforming the raw materials into a material that can be used to create finished product. This is the creation of “resin”, so this is what we do at Cereplast. We use the agricultural raw materials and transform it into the building block of the plastic industry.
3. The third and final step, which is the transformation of those resin pellets into consumer product. a telephone, forks, spoons, automotive, etc”
What is the cost comparison against traditional plastic?
An important aspect also is that bioplastic are resolving a lot of issues that needs to be quantified such costs of clean up, costs of carbon dioxide emissions, costs of oil foreign policy, etc.”
CEOCFO: Who is using your products?
Mr. Scheer: “We have a wide area of industries using our resins. We offer two families of resins: the Compostables®. Basically, Compostable means that the product when used can be discarded in a commercial compost site instead of a landfill, and the product will go back to nature in a very short period of time, anywhere from three to six months with no chemical residue. The compostable products are primarily used in the packaging industry and the food service industry. Our clients are very large companies like Georgia Pacific, Solo Cup, Genpak, Innoware to all of the large brand owners like Danone, etc. The second family of resins are the Hybrid®Resins, which are basically traditional resins with a high percentage of of renewable resource. It is used primarily in durable application, such as the automotive industry, the consumer product industry, furniture, construction and others which are really targeting durable applications.”
CEOCFO: You recently announced a new strategic plan; what is the plan going forward?
Mr. Scheer: “Cereplast has been successful in two activities:
1. The first activity is clearly design and development of resin and we have been very good at designing and developing resin. Over the past seven years, basically what we have done is created a very strong portfolio of patents. We have about 48 patents that we have developed in-house or in conjunction with universities that we are working with.
2. The second activity consists of taking those resins and creating applications for those resins, making sure they are going to run on traditional equipment, with no investments from the plastic fabricators. We signed a lot of very large companies like Georgia Pacific to the Danone.
3. Then we had a third activity consisting of manufacturing the resins and frankly, in the current environment manufacturing is extremely labor and capital intensive. In addition, there is a lot of excess capacity in terms of manufacturing. So we recently decided to find a partner that will run and manufacture on our behalf under our control. We believe that it will free a lot of our capital and labor resources and will enable for to concentrate our strength on design and development of resin, because this is where our forte is.”
Mr. Scheer: “We have no real competition, and let me explain to you; in the past seven years the company has never lost any contracts or programs to any bio-plastic competition. There are companies that are in the bio-plastic arena, but their purpose is very complementary to what we do and we really don’t compete against each other. If I look at the companies around in the bio-plastic arena, you have a hand full of companies. Worldwide there are about 5 legitimate companies. There are companies that are making polymers, those raw materials that need to be used to create resin. Among them I will list a company called NatureWorks, which is a venture between of Cargill and Teijin. Basically what they do is make a polymer called Polylactic Acid (PLA). You have another company called Metabolix, which soon will be making a polymer called PHA. Then you have some companies over seas such as Novamont in Italy, primarily targeting the European markets. Then you have Cereplast, which is one of the larger dominant players in the marketplace here. Then you have small divisions of large chemical companies such as Dupont, BASF, Arkema and those companies are starting to explore the possibility of entering the market of bio-plastic. In the next five to ten years those very large chemical groups will start to invest substantial amount of money into that arena, because they do realize that it is going to be the market of the 21st century.”
CEOCFO: Why should potential investors look at Cereplast today?
“For potential investors we are the leader in what we are doing. It is
clearly an industry that is in infancy, but it is also clearly an industry
that is going to grow substantially in the next five years. The large
chemical companies are clearly looking at what we are doing, and with our
strong Intellectual property portfolio, they will have to consider Cereplast.
When I say consider Cereplast, it means that they will consider doing
ventures or partnerships with us, or eventually consider an acquisition,
because we have a strong portfolio of patents that are going to be necessary
for them to enter that arena. We have clearly created an IP barrier for
those companies. Another aspect of it is that the company is a public entity
traded on the bulletin board and clearly, we have been at the lowest
valuation ever. Right now, our stock is being traded below twenty cents per
stock. We have a market capitalization of $40 million. In the long-run why
investors should look at us, because if you do your due diligence and look
at the quality of the clients that Cereplast has been able to sign, we have
signed only Fortune 50 companies.”
CEOCFO: Final thoughts, what should people take away from this interview about Cereplast?
they should remember most is two things. First, Cereplast is a leader in the
bio-plastic arena. Cereplast is a very strong candidate with a very strong
intellectual property and patent portfolio. We have a technology that nobody
can accessbecause of this IP protection.”
“Cereplast has been successful in two activities: The first activity is clearly design and development of resin and we have been very good at designing and developing resin. Over the past seven years, basically what we have done is created a very strong portfolio of patents. We have about 48 patents that we have developed in-house or in conjunction with universities that we are working with. The second activity consists of taking those resins and creating applications for those resins, making sure they are going to run on traditional equipment, with no investments from the plastic fabricators. We signed a lot of very large companies like Georgia Pacific to the Danone.” - Frederic Scheer
ceocfointerviews.com does not purchase or
recommendation on stocks based on the interviews published.